Cycad Group Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 3

- Investments
- 44
- Portfolio
- 10
- Exits
- 23

Cycad Group General Information
Description
Cycad Group is a venture capital firm focusing on investments in companies with enabling solutions, disruptive technologies and innovative products. It pursues investment opportunities in the areas of life sciences (e.g., therapeutics, medical devices, diagnostics and analytical tools), energy technologies, and advanced materials and chemical processes. The firm was founded in 2000 and is based in Santa Barbara, California.
Contact Information
- 1270 Coast Village Circle
- Suite 100
- Santa Barbara, CA 93108
- United States
Cycad Group Investments (44)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Formetrix | 23-Aug-2018 | Early Stage VC | 00.00 | Industrial Supplies and Parts | Generating Revenue | 0. 0000000 000000 00 |
00000000 | 05-Oct-2017 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | |
00000000 | 14-Sep-2017 | 00000 00000 | 00.000 | Diagnostic Equipment | Clinical Trials - General | 0. 0000000 000000 00 |
00000 000000000000 | 21-Aug-2017 | 00000 00000 | 00000 | Biotechnology | Generating Revenue/Not Profitable | |
00000000 000000000 | 03-Aug-2017 | 00000 00000 | 00000 | Drug Delivery | Profitable | |
000000000 0000000 | 13-May-2015 | 00000 00000 | 000.00 | Surgical Devices | Generating Revenue | 000000 00000 |
00000000 | 15-May-2014 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
00000000 | 08-May-2014 | 00000 00000 | 000.00 | Diagnostic Equipment | Clinical Trials - General | 0. 0000000 000000 00 |
SOFIE | 15-Oct-2013 | Early Stage VC | 000 | Diagnostic Equipment | Generating Revenue | 0. 0000000 000000 00 |
Genocea Biosciences | 02-Jul-2013 | Later Stage VC | 000.00 | Drug Discovery | Generating Revenue/Not Profitable |
Cycad Group Exits (23)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Ziopharm Oncology | 05-Feb-2020 | Secondary Transaction - Open Market | 000.00 |
00000000 | 31-Aug-2018 | 000000000000000000 | 00000 |
00000 000000000000 | 03-May-2018 | 000 | 0000 |
000000000 0000000 | 20-Sep-2017 | 000000000000000000 | 00000 |
000000000 | 11-Sep-2017 | 000000000000000000 | 00000 |
0000000 0000000000 | 05-Feb-2014 | 000 | 0000 |
00000 000000 | 01-Feb-2014 | 000 00 00000000 | |
000000 00000 | 01-Jan-2014 | 0000000000: 000000 | |
SpectraFluidics | 01-Jan-2014 | Bankruptcy: Liquidation | |
Agile RF | 01-Aug-2013 | Out of Business |
Cycad Group Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialCycad Group Team (3)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
K. Leonard Judson JD | Co-Founder, President and Managing Director | 0 | 0 | Santa Barbara, CA | |
Robert Balch | Senior Vice President | 0 | 0 | Santa Barbara, CA | |
Paul Glenn JD | Chairman & Director | 0 | Santa Barbara, CA |
Cycad Group Co-Investors (46)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Baillie Gifford | 2 | 0 |
![]() |
![]() |
|
Bill & Melinda Gates Foundation | 0 | 0 | 0 |
![]() |
![]() |
ARCH Venture Partners | 0 | 0 |
![]() |
![]() |
|
Allegheny Financial Group | 0 | 0 |
![]() |
![]() |
|
The Invus Group | 0 | 0 |
![]() |
![]() |